How to Know if a Stock Will Meet or Surpass Its Quarterly Review

  • S&P 500

  • Dow xxx

  • Nasdaq

  • Russell 2000

  • Crude Oil

  • Gold

  • Silver

  • EUR/USD

  • 10-Twelvemonth Bond

  • GBP/USD

  • USD/JPY

  • BTC-USD

  • CMC Crypto 200

  • FTSE 100

  • Nikkei 225

Humana (HUM) Q4 Earnings Surpass Estimates

Humana (HUM) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Approximate of $1.23 per share. This compares to loss of $ii.30 per share a year ago. These figures are adjusted for not-recurring items.

This quarterly report represents an earnings surprise of 0.81%. A quarter agone, it was expected that this wellness insurer would postal service earnings of $4.61 per share when information technology actually produced earnings of $4.83, delivering a surprise of 4.77%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Humana , which belongs to the Zacks Medical - HMOs manufacture, posted revenues of $21.05 billion for the quarter ended December 2021, missing the Zacks Consensus Estimate by 0.62%. This compares to year-ago revenues of $19.06 billion. The company has topped consensus revenue estimates merely in one case over the last 4 quarters.

The sustainability of the stock's firsthand toll movement based on the recently-released numbers and future earnings expectations will generally depend on direction's commentary on the earnings call.

Humana shares have lost about 15.8% since the kickoff of the year versus the Due south&P 500's reject of -iv.half-dozen%.

What's Next for Humana?

While Humana has underperformed the market so far this year, the question that comes to investors' minds is: what'south side by side for the stock?

There are no easy answers to this key question, just i reliable measure that can help investors address this is the company's earnings outlook. Not just does this include current consensus earnings expectations for the coming quarter(s), simply also how these expectations have changed lately.

Empirical inquiry shows a strong correlation between near-term stock movements and trends in earnings judge revisions. Investors tin can rails such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive runway tape of harnessing the power of earnings approximate revisions.

Alee of this earnings release, the judge revisions trend for Humana: unfavorable. While the magnitude and management of estimate revisions could modify following the visitor's just-released earnings report, the current condition translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the most future. You lot can run into the complete list of today'due south Zacks #i Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and current financial year modify in the days alee. The current consensus EPS gauge is $7.l on $22.92 billion in revenues for the coming quarter and $23.83 on $91.76 billion in revenues for the current fiscal year.

Investors should exist mindful of the fact that the outlook for the industry can have a material bear upon on the performance of the stock as well. In terms of the Zacks Manufacture Rank, Medical - HMOs is currently in the bottom 20% of the 250 plus Zacks industries. Our enquiry shows that the top fifty% of the Zacks-ranked industries outperform the bottom 50% past a factor of more than ii to 1.

Some other stock from the same industry, The Joint Corp. (JYNT), has notwithstanding to written report results for the quarter concluded December 2021.

This company is expected to mail quarterly earnings of $0.08 per share in its upcoming report, which represents a year-over-twelvemonth modify of -33.iii%. The consensus EPS gauge for the quarter has remained unchanged over the last thirty days.

The Joint Corp.'s revenues are expected to be $22.21 million, up xxx.3% from the year-agone quarter.

fitzgeraldcoundel.blogspot.com

Source: https://finance.yahoo.com/news/humana-hum-q4-earnings-surpass-130501756.html

0 Response to "How to Know if a Stock Will Meet or Surpass Its Quarterly Review"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel